Two days were reserved by the European Patent Office to hear an appeal over the application for a stem cell patent. But only one was needed in the end.
Supreme Court Rulings and patent reform are making it harder to defend patents in the US – and biotechs are falling back on trade secrets to protect their IP.
Brussels is abuzz with speculation that Europe’s fragmented, costly and complex patent regime is about to reform – aided by advances in machine translation. But support is not unanimous.
On current growth rates China will overtake the US to become the world’s largest patent filing jurisdiction by 2012, according to market analysts Evalueserve.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.